Related Experiment Video

Updated: Nov 19, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.7K

Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell

Jatin Shah1, Sharon Shacham1, Michael Kauffman1

  • 1Karyopharm Therapeutics, Inc., Newton, MA 02459, USA.

Future Oncology (London, England)
|February 2, 2021
PubMed

Keywords:
EQ-5D-5LFACT-Lymdiffuse large B-cell lymphomadisutility of adverse eventshealth state utilityhealth utilityhealth-related quality of lifepatient-reported outcomesselinexor

More Related Videos

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics08:29

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

15.0K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K